Careers Contact Locations

OPKO Health, Inc.

  • Home
  • Who We Are
    • Our Vision
    • Our History
    • Our Leadership
  • What We Do
    • Overview
    • Our Products
    • Our Solutions
    • Our Technology
    • Our Research
    • Our Diagnostics
  • News & Media
    • Press Releases
    • Announcements
    • Events
    • Presentations
  • Investors
    • Overview
    • News / Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Careers
  • Contact
  • Locations

OPKO Acquires ModeX Therapeutics

Learn More

Press Releases

News & Media

News & Media

  • Press Releases
  • Announcements
  • Events
  • Presentations

OPKO Announces Positive Topline Results In Phase 2 Diabetes And Obesity Trial

Mar 21, 2019

OPKO Health Reports 2018 Fourth Quarter Business Highlights and Financial Results

Feb 27, 2019

OPKO Health to Announce Fourth Quarter 2018 Financial Results on February 27, 2019

Feb 26, 2019

OPKO Health, Inc. Announces the Pricing of its Offering of Convertible Senior Notes

Feb 5, 2019

OPKO Health, Inc. Announces Proposed Offering of Convertible Senior Notes

Feb 4, 2019

OPKO Health Receives FDA Approval for the Point-of-Care Sangia PSA Test with the Claros® 1 Analyzer

Feb 1, 2019

OPKO Provides Update on the Development of OPK-88004, a Selective Androgen Receptor Modulator

Jan 31, 2019

Future Non-Coverage Determination for 4Kscore Test Posted by Novitas

Jan 31, 2019

OPKO Health Appoints Jon R. Cohen, M.D. Executive Chairman of BioReference Laboratories

Jan 7, 2019

OPKO Health and OPKO's CEO and Chairman, Dr. Phillip Frost, Announce Proposed Resolution of SEC Action

Dec 27, 2018
RSS
  • Prev
    • 1...
    • 7
    • 8
    • 9
    • 10
    • 11
    • 12
    • 13
    • 14
    • 15
    • 16
    • ...47
    Next
    © 2022 OPKO Health, Inc. All Rights Reserved.
    Privacy Policy Governance Terms of Use Sitemap